{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:03:56Z","timestamp":1791097436134,"version":"4.1.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,9,29]],"date-time":"2007-09-29T00:00:00Z","timestamp":1191024000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s11845-007-0087-x","type":"journal-article","created":{"date-parts":[[2007,9,28]],"date-time":"2007-09-28T08:00:53Z","timestamp":1190966453000},"page":"309-311","source":"Crossref","is-referenced-by-count":15,"title":["Pneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis"],"prefix":"10.1007","volume":"176","author":[{"given":"C.","family":"Lahiff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. B.","family":"Khiaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"Chadwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,29]]},"reference":[{"key":"87_CR1","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM199011223232131","volume":"323","author":"The National Institute of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia","year":"1990","unstructured":"The National Institute of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia (1990) Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 323:1500\u20131504","journal-title":"N Engl J Med"},{"key":"87_CR2","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1378\/chest.113.5.1215","volume":"113","author":"JG Pareja","year":"1998","unstructured":"Pareja JG, Garland R, Koziel H (1998) Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 113:1215\u20131224","journal-title":"Chest"},{"issue":"6","key":"87_CR3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-4632.2004.02571.x","volume":"44","author":"M Bakleh","year":"2005","unstructured":"Bakleh M, Tleyjeh I, Matteson EL, Osmon DR, Berbari EF (2005) Infectious complications of tumor necrosis factor-\u03b1 antagonists. Int J Dermatol 44(6):443\u2013448","journal-title":"Int J Dermatol"},{"key":"87_CR4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1056\/NEJM199901283400401","volume":"340","author":"ME Weinblatt","year":"1999","unstructured":"Weinblatt ME, Kremer JM, Bankhurst AD et al (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253\u2013259","journal-title":"N Engl J Med"},{"key":"87_CR5","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra032906","volume":"350","author":"NJ Olsen","year":"2004","unstructured":"Olsen NJ, Stein CM (2004) New drugs for rheumatoid arthritis. N Engl J Med 350:2167\u20132179","journal-title":"N Engl J Med"},{"key":"87_CR6","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/rheumatology\/34.7.677","volume":"34","author":"KA Oien","year":"1995","unstructured":"Oien KA, Black A, Hunter JA, Madhok R (1995) Pneumocystis carinii pneumonia in a patient with rheumatoid arthritis, not on immunosuppressive therapy and in the absence of human immunodeficiency virus infection. Br J Rheumatol 34:677\u2013679","journal-title":"Br J Rheumatol"},{"issue":"1","key":"87_CR7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/s10165-005-0454-2","volume":"16","author":"S Mori","year":"2006","unstructured":"Mori S, Imamura F, Kiyofuji C et al (2006) Pneumocystis jiroveci pneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumour necrosis factor alpha neutralizing antibody. Mod Rheumatol 16(1):58\u201362","journal-title":"Mod Rheumatol"},{"key":"87_CR8","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2214\/ajr.169.4.9308446","volume":"169","author":"JF Gruden","year":"1997","unstructured":"Gruden JF, Huang L, Turner J et al (1997) High-resolution CT in the evaluation of clinically suspected Pneumocystis carinii pneumonia in AIDS patients with normal, equivocal, or nonspecific radiographic findings. AJR Am J Roentgenol 169:967\u2013975","journal-title":"AJR Am J Roentgenol"},{"key":"87_CR9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-124-6-199603150-00008","volume":"124","author":"JH Shelhamer","year":"1996","unstructured":"Shelhamer JH, Gill VJ, Quinn TC et al (1996) The laboratory evaluation of opportunistic pulmonary infections. Ann Intern Med 124:585\u2013599","journal-title":"Ann Intern Med"},{"key":"87_CR10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/rheumatology\/keh071","volume":"43","author":"K Saito","year":"2004","unstructured":"Saito K, Nakayamada S, Nakano K et al (2004) Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases. Rheumatology (Oxford) 43:479\u2013485","journal-title":"Rheumatology (Oxford)"},{"key":"87_CR11","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(01)05705-1","volume":"358","author":"R Navin","year":"2001","unstructured":"Navin R (2001) Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of Pneumocystis carinii pneumonia in patients with HIV-1: a prospective study. Lancet 358:545\u2013549","journal-title":"Lancet"},{"issue":"1","key":"87_CR12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/milmed\/161.1.58","volume":"161","author":"S Krebs","year":"1996","unstructured":"Krebs S, Gibbons RB (1996) Low-dose methotrexate as a risk factor for Pneumocystis carinii pneumonia. Mil Med 161(1):58\u201360","journal-title":"Mil Med"}],"container-title":["Irish Journal of Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-007-0087-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11845-007-0087-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-007-0087-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:09:20Z","timestamp":1559430560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11845-007-0087-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,29]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["87"],"URL":"https:\/\/doi.org\/10.1007\/s11845-007-0087-x","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,29]]}}}